<DOC>
	<DOCNO>NCT00312247</DOCNO>
	<brief_summary>The purpose research study understand walk pattern , strength function change boys Duchenne muscular dystrophy on/off corticosteroid determine best timing treatment option maintain walk long possible .</brief_summary>
	<brief_title>Biomechanical Analysis Gait Individuals With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description>Duchenne muscular dystrophy ( DMD ) X-linked recessive disease muscle characterize progressive loss functional muscle mass , replace fibrofatty tissue . Historically , boys DMD lose ability walk age 8-12 year , due progressive weakness quadriceps couple development contracture hip , knee ankle . This progressive loss function necessitate individual DMD spend less time walk time wheelchair , lead development spinal deformity . Recently , corticosteroid show reduce expect loss muscle strength , extend time ambulation stand maintain , minimize eliminate spinal deformity individual DMD ; yet , side effect treatment preclude use patient . To date , difference gait pattern marker disease progression boys corticosteroid utilize treatment objectively quantify . This lack knowledge major obstacle determine effective treatment subset boys DMD .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Confirmed diagnosis DMD Male . Four year age old . Ability walk independently five minute 10 minute selfselected speed . Ability cognitively understand direction test procedure . Female Nonambulatory</criteria>
	<gender>Male</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Walking</keyword>
	<keyword>Muscle Strength</keyword>
	<keyword>Energy Cost</keyword>
	<keyword>Quality Life</keyword>
</DOC>